Use of diagnostic coronary angiography in women and men presenting with acute myocardial infarction:a matched cohort study by Bjerking, Louise Hougesen et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Use of diagnostic coronary angiography in women and men presenting with acute
myocardial infarction
Bjerking, Louise Hougesen; Hansen, Kim Wadt; Madsen, Mette; Jensen, Jan Skov; Madsen,
Jan Kyst; Sørensen, Rikke; Galatius, Søren
Published in:
BMC Cardiovascular Disorders
DOI:
10.1186/s12872-016-0248-9
Publication date:
2016
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Bjerking, L. H., Hansen, K. W., Madsen, M., Jensen, J. S., Madsen, J. K., Sørensen, R., & Galatius, S. (2016).
Use of diagnostic coronary angiography in women and men presenting with acute myocardial infarction: a
matched cohort study. BMC Cardiovascular Disorders, 16, [120]. https://doi.org/10.1186/s12872-016-0248-9
Download date: 03. Feb. 2020
RESEARCH ARTICLE Open Access
Use of diagnostic coronary angiography
in women and men presenting with acute
myocardial infarction: a matched cohort
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Abstract
Background: Based on evident sex-related differences in the invasive management of patients presenting with
acute myocardial infarction (AMI), we sought to identify predictors of diagnostic coronary angiography (DCA) and
to investigate reasons for opting out an invasive strategy in women and men.
Methods: The study was designed as a matched cohort study. We randomly selected 250 female cases from a
source population of 4000 patients hospitalized with a first AMI in a geographically confined region of Denmark
from January 2010 to November 2011. Each case was matched to a male control on age and availability of cardiac
invasive facilities at the index hospital. We systematically reviewed medical records for risk factors, comorbid
conditions, clinical presentation, and receipt of DCA. Clinical justifications, as stated by the treating physician, were
noted for the subset of patients who did not receive a DCA.
Results: Overall, 187 women and 198 men received DCA within 60 days (75 % vs. 79 %, hazard ratio: 0.82 [0.67-1.00],
p = 0.047).In the subset of patients who did not receive a DCA (n = 114), clinical justifications for opting out an invasive
strategy was not documented for 21 patients (18.4 %). Type 2 myocardial infarction was noted in 11 patients (women
versus men; 14.5 % vs. 3.8 %, p = 0.06) and identified as a potential confounder of the sex-DCA relationship.
Receipt of DCA was predicted by traditional risk factors for ischaemic heart disease (family history of cardiovascular
disease, hypercholesterolemia, and smoking) and clinical presentation (chest pain, ST-segment elevations). Although
prevalent in both women and men, the presence of relative contraindications did not prohibit the use of DCA.
Conclusion: In this matched cohort of patients with a first AMI, women and men had different clinical presentations
despite similar age. However, no differences in the distribution of relative contraindications for DCA were found
between the sexes. Type 2 MI posed a potentiel confounder for the sex-related differences in the use of DCA.
Importantly,clinical justification for opting out an invasive strategy was not documented in almost one fifth of patients
not receiving a DCA.
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Background
Ischemic heart disease (IHD) constitutes the leading
cause of years of life lost worldwide and is one of the
leading causes of death in both women and men [1].
Despite recommendations for similar treatment of
women and men presenting with acute myocardial in-
farction (AMI) by the European Society of Cardiology
and the Danish Society of Cardiology [2, 3], differ-
ences in invasive management of women and men
have been widely reported [4–7]. The majority of
studies have compared men and women with AMI at
different ages prohibiting an appropriate comparison
of baseline characteristics and comorbidities. More-
over, it has not been properly investigated whether
clinical justifications for opting out an invasive strat-
egy in patients presenting with AMI differ between
women and men. The objective of this study was to
characterize an age-matched cohort of women and men
hospitalized with AMI, and to investigate reasons for
opting out an invasive treatment strategy in a real-
world setting.
Methods
Design overview
This study was designed as a matched cohort study.
Using all patients hospitalized between 1 January 2010
and 2 November 2011 with a first AMI in the Greater
metropolitan area surrounding Copenhagen (n = 4000)
as our source population, we randomly selected 250 fe-
male cases and matched them in a 1:1 ratio with 250
male controls based on age and availability of cardiac
invasive facilities in the index hospital. This matched
cohort of 500 patients constituted our study population
(Fig. 1) for which we conducted a systematic, retro-
spective collection of patient data from medical re-
cords. Patients were followed for 60 days. We identified
predictors of receiving a cardiac catheterization during
follow-up, frequencies of relative contraindications
Fig. 1 Flowchart. Flow chart showing the selection of the study population from the source population
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for coronary angiography, and documented reasons
for opting out an invasive treatment strategy.
Settings
The greater metropolitan area surrounding Copenhagen
included 10 hospitals with medical admission wards plus
two high-volume hospitals with invasive heart centers
performing diagnostic coronary angiography (DCA), per-
cutaneous coronary intervention (PCI) and coronary
artery bypass graft surgery (CABG). The hospital catch-
ment areas covered the greater northern capital area and
a smaller remote island (Bornholm); a total of 1.68 mil-
lion inhabitants in 2010 [8]. Pre-hospital triage ensured
direct transport of patients presenting with ST-segment
elevation myocardial infarction (STEMI) to treatment
with primary PCI at an invasive heart center. Non-ST-
segment elevation myocardial infarction (NSTEMI)
patients were in general initially treated at the nearest
hospital and subsequently referred to an invasive heart
center for further invasive assessment. The guidelines
for treatment of AMI issued by the Danish society of
Cardiology follow those of European Society of Cardi-
ology [9] and explicitly state that, unless contraindicated,
all patients with AMI irrespective of sex should be
offered a DCA.
Patients
We identified a source population of patients hospi-
talized with a first AMI from 1 January 2010 to 2
November 2011 from the Danish National Patient
Register, which contains information on all hospital
admissions in Denmark since 1978 [10]. The Inter-
national Classification of Diseases (ICD) 10th revision
codes for AMI (I21-I21.9) in the Danish National Pa-
tient Register have previously been validated showing
a positive predictive value of 93.5 % [11]. We linked
data on dates of index admission, index hospital, and
cardiac procedures to information on dates of death
from the Danish Register of Causes of Death and
demographics from the Danish Civil Registration
System using the unique personal civil registration
number provided to all Danish citizens at birth or
immigration. Further restrictions to the source po-
pulation were applied; Patients discharged on the day
of admission were excluded, as they were unlikely to
have experienced an actual myocardial infarction.
Similarly, death on the day of admission rendered
patients ineligible for invasive treatment and thus
were excluded. Finally, we excluded patients younger
than 30 years, since AMI in this age group are rarely
related to atherosclerosis, and patients older than
90 years, due to frailty in this elderly group [12–14].
From the source population a random draw of 250
female cases matched with 250 male controls of similar
age and similar access to invasive cardiac treatment at
index hospital constituted the study population. The
matching procedure was performed using the MatchIt
package [15] of statistical software R, version 3.1.0 [16].
Data collection
Patient-level clinical data was collected from electronic
medical records. The collection process was standard-
ized using pretested extraction sheets (Additional file 1:
Extraction sheet) in order to ensure consistent and com-
parable data. Each extraction sheet was divided into
seven main topics: 1) index admission, 2) risk factors, 3)
comorbidities, 4) electrocardiographic (ECG) findings,
5) clinical presentation, 6) in-hospital medications, and
7) blood test results. Only information available to the
treating physicians prior to any cardiac catheterization
was collected; in patients who did not receive a DCA all
information from the hospital stay was collected. Data
was entered in an electronic database and compiled with
register-based data using the personal civil registration
number as described above. Data collection, analysis and
interpretation were performed by one specially trained
individual (LHB) to ensure consistency and reproducibility.
Upon completing the initial data collection process, the
process was repeated for the initial 80 medical records
and compared the obtained data in order to address
potential intra-observer variability.
Contextual variables
For each patient not receiving a coronary angiography
we noted the clinical justification, as stated in the med-
ical record by the treating physician, word-for-word and
categorized them into 11 arbitrarily defined groups:
DCA already performed, death before DCA, DCA de-
clined by patient, DCA not possible to perform or not
indicated, comorbidities/bad habitual conditions, lack
of symptoms, type 2 MI, high age, DCA not men-
tioned in the medical record, no AMI, and other. The
diagnosis of type 2 MI was assigned when one of two
conditions was met: (1) the treating physician docu-
mented the qualifying AMI event as a type 2 myocar-
dial infarction directly in the medical records, or (2)
the reasons stated by the treating physician for opting
out a DCA were consistent with criteria listed in the
international definition of type 2 MI [17]. The definitions
of relative contraindications for cardiac catheterization
were based on guidelines developed by the Danish
Society of Cardiology [18]. Uncontrolled hypertension,
fever or active infection, malignant or terminal disease,
risk of bleeding, ongoing bleeding, moderate to severe
heart failure, previous allergy to contrast, digoxin
intoxication, and electrolyte disturbances were all
considered as individual relative contraindications for
DCA. We used data collected from electronic medical
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records for quantifying the distribution of these
relative contraindications in the study population. We
defined uncontrolled hypertension as an elevated sys-
tolic blood pressure (SBP) > [180 mmHg] or diastolic
blood pressure (DBP) > [110 mmHg]). Fever or active
infection was defined as a white blood cell count
(WBC) above 8.8 x 109/liter or temperature more
than 38 degrees Celsius. Malignant or terminal disease
was defined as severe anemia with hemoglobin below
6 mM or renal failure with serum-creatinine above
250 mM. Risk of bleeding was defined as a platelet
count below 145 μM or an International Normalized
Ratio (INR) above 1.2, and moderate to severe heart
failure as a history of heart failure, or clinical findings
of neck vein distension, dependent edema, or pulmonary
edema. Electrolyte disturbances were defined as potas-
sium levels above 4.6 or below 3.5 mM.
All collected ECG findings and blood test results
were those available to the treating physician as upon
hospitalization; but always prior to the time of cardiac
catheterization in patients receiving a DCA. The only
exception was the second measurement of troponins
(“troponin II”) and the highest troponin value measured
during hospitalization (“peak troponin”) which was some-
times only available subsequent to a coronary angiog-
raphy. As different troponin assays were used across
hospitals we standardized all troponin-levels against the
upper reference limit to enable comparisons.
Statistical methods
We present discrete data as counts and percentages, and
continuous data as median and interquartile range
(IQR). Categorical data were compared using a Chi-
squared test or, if the expected number of observations
in a group were less than five, using Fisher’s exact
test. Continuous data were analyzed using the non-
parametric Mann-Whitney U-test. In order to identify
predictors of DCA we constructed uni- and multivari-
able logistic regression models with receipt of coron-
ary angiography within 60 days as the dependent
variable and patient characteristics as independent
variables. The multivariable logistic regression model
was build using a backwards stepwise procedure using
a p-value of 0.10 as cutoff for inclusion. The final
model was tested for collinearity and interactions.
Time-to-event analyses of all-cause death and receipt
of DCA were conducted using proportional hazards
Cox regressions. The assumption of proportional haz-
ards was assessed with log-log curves and by testing
the Schoenfeld residuals for time-dependency. As-
sumptions were found valid. All statistical tests had a
two-sided significance level of 0.05. The analyses were
conducted using Stata Statistics/Data analysis, MP
14.0 StataCorp, Texas, USA.
Results
The matching procedure successfully balanced the 250
women and 250 men on age and type of index hospital
(Additional file 2: Table S1). The study population con-
tained more elderly patients than the source population
as expected from the use of female cases. Complete
medical records were available for 499 patients (Fig. 1).
Table 1 shows baseline characteristics of the study
population. A higher proportion of women had heart
failure and a family history of cardiovascular diseases
(CVD) compared to men. In contrast, more men than
women had known ischemic heart disease (IHD), prior
PCI, and prior CABG. Numerically, men were more
likely to have chest pain than women, whereas more
women presented with atypical symptoms such as nau-
sea and vomiting. The only significant difference in
ECG patterns was a higher proportion of ST-
depressions among men compared to women, although
a tendency toward a higher rate of left bundle branch
block (LBBB) among women was apparent. Women
presented with higher systolic blood pressure, and heart
rate but lower serum-creatinine levels than men. Cor-
onary angiography was performed in 385 patients
(77.2 %) within 60 days of index hospitalization; 198
men and 187 women. Thus, the cumulative incidence
of DCA at 60 days was higher for men than women
(79.2 % vs. 75.1 %, HR 0.82 [0.67-1.00], p = 0.047).
There was no significant difference in all-cause mortal-
ity at 60 days between women and men (9.6 % vs.
10.4 %, HR 0.91 [0.52-1.59], p = 0.74), even when sepa-
rated into age-quartiles (Additional file 3: Table S2).
In terms of relative contraindications for DCA women
were more likely to have electrolyte-disturbances than
men (Table 2). Compared to men, there was a trend to-
wards more cases of uncontrolled hypertension among
women, as well as a higher proportion of women with at
least one relative contraindication. Among the two most
common relative contraindications, uncontrolled hyper-
tension, and risk of bleeding, no sex-related differences
were found. The presence of relative contraindications
did not preclude the use of DCA.
Table 3 displays univariable predictors of DCA at
60 days. Admission to a hospital with invasive cardiac
facilities, known family history of CVD, hypertension,
hypercholesterolemia, smoking, and chest pain were all
associated with a higher use of DCA. On the other
hand, previous CABG, valvular heart disease, atrial fib-
rillation, COPD, renal failure, stroke, dyspnea, and
abdominal pain were associated with less use of DCA.
After multivariable analysis arterial hypertension,
hypercholesterolemia, smoking, known IHD, chest pain,
and ST-elevation persisted as significant positive
predictors of DCA. Age, prior CABG, COPD, renal
failure, stroke, and Q-wave were negative predictors
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Table 1 Baseline characteristics and clinical presentations
Study Cohort Women Men p-value
Number n = 499 n = 249 n = 250 n = 499
Age median(IQR) 74 (62-81) 74 (62-81) 0.96
Admission to invasive heart center 89 (35.6) 92 (36.8) 0.78
Risk factors
Family history of CVD 80 (32.1) 61 (24.4) 0.06
Arterial hypertension 122 (49.0) 119 (47.6) 0.76
Diabetes mellitus 36 (14.5) 39 (15.6) 0.72
Hypercholesteroleamia 80 (32.1) 85 (34.0) 0.7
Smoking 69 (27.7) 82 (32.8) 0.08
Prior PCI 6 (2.4) 16 (6.4) 0.047
Prior CABG 6 (2.4) 21 (8.4) 0.005
Previous MI 9 (3.6) 9 (3.6) 0.99
Co-morbidities
Heart-related
Known IHD 20 (8.0) 46 (18.4) 0.001
Heart failure 35 (14.1) 19 (7.6) 0.020
Valvular heart disease 26 (10.4) 19 (7.6) 0.27
Atrial fibrillation 39 (15.7) 40 (16.0) 0.92
Other
COPD 23 (9.2) 27 (10.8) 0.56
PAOD 14 (5.6) 20 (8.0) 0.29
Renal failure 11 (4.4) 9 (3.6) 0.66
Neoplasia 4 (1.6) 12 (4.8) 0.07
Liver failure 0 (0.0) 1 (0.4) 1.00
Stroke 25 (10.0) 31 (12.4) 0.40
Symptoms
Chest pain 189 (75.9) 203 (81.2) 0.15
Dyspnea 96 (38.6) 81 (32.4) 0.15
Neck pain 25 (10.0) 21 (8.4) 0.53
Diaphoresis 30 (12.1) 36 (14.4) 0.44
Nausea/vomiting 47 (18.9) 31 (12.4) 0.046
Fatigue 7 (2.8) 8 (3.2) 0.8
Abdominal pain 14 (5.6) 8 (3.2) 0.19
Back pain 27 (10.8) 21 (8.4) 0.36
Cardiac arrest 15 (6.0) 14 (5.6) 0.84
Other competing acute conditions at admission?a 42 (16.9) 34 (13.6) 0.31
ECG
ST-elevations 104 (41.8) 107 (42.8) 0.82
ST-depressions 59 (23.7) 86 (34.4) 0.008
LBBB 24 (9.6) 16 (6.4) 0.18
Q-wave 37 (14.9) 38 (15.2) 0.92
Systolic blood pressuree 140 (126-160) 137 (119.5-155) 0.013
Heart ratee 88 (70-105) 81 (66-97) 0.008
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of DCA (Table 4). In total 114 patients (22.9 %) did
not receive a DCA; 52 men and 62 women. Clinical
justifications for opting out an invasive treatment
strategy, as stated by the treating physician, are summa-
rized in Fig. 2. Most frequent reasons were multiple
comorbidities or poor habitual condition (19.3 %),
patients who declined invasive examination (16.7 %), or
DCA not deemed feasible or indicated (16.7 %). Not-
ably, in 21 (18.4 %) of the cases no reason at all for
opting out a coronary angiography was documented in
the medical record by the treating physician. There
were no significant sex-related differences in any of
the 11 groups, but a trend towards more cases of
type 2 MI in women compared to men (14.5 % vs.
3.8 %, p = 0.06).
Discussion
Key findings
This study used detailed clinical information from 500
medical records of patients hospitalized with a first
AMI to investigate the clinical basis for referring men
and women to DCA. Classical risk factors, symptoms
and clinical findings predicted the receipt of DCA in
this matched cohort. Women had an 18 % lower risk
for receipt of DCA at 60 days than men, but a similar
risk for all-cause mortality despite accounting for dif-
ferences in age and type of index hospital. Surpris-
ingly, no clinical justification for refraining from an
invasive treatment strategy was documented in almost
one fifth of the records of patients who did not re-
ceive a DCA.
Interpretations
The matched design of our study was intended to address
two issues. First, it has been suggested that differences in
patient characteristics, treatments and outcomes can
largely be attributed to the differences in age between
women and men presenting with ischemic heart disease
[6]. Second, the use of cardiac catheterization is strongly
associated with hospital-availability of this procedure [19].
By matching on age and hospital, these confounding
effects were managed prior to our analyses. Despite
the somewhat limited power of our analyses, we iden-
tified significant differences in patient characteristics
between women and men of similar age; i.e. heart
failure was more prevalent in women while more
men presented with known IHD and prior revascular-
izations. Based on these findings a sex-related dif-
ference in the etiology of AMI seems more plausible
than age in explaining previously observed differences
in characteristics between women and men [20].
Our logistic and Cox proportional hazards regres-
sion analyses yielded differing results in terms of the
association between sex and receipt of DCA. The rea-
son for this lies in the poorer power of the logistic
regression which only incorporates counts, as com-
pared to the Cox regression modeling time-to-event
data. We relied on the results of the latter, as the lo-
gistic regression attributes equal weights to early and
late procedures and thus does not address the timing
of DCAs, which we deemed of clinical relevance.
Thus, despite women having a lower risk for DCA at
60 days than men, we were unable to demonstrate
any significant differences in the most common
Table 1 Baseline characteristics and clinical presentations (Continued)
Troponin level Ib,c,e 3.2 (1.4-9.2) 2.5 (1.0-8.4) 0.25
Troponin level IIb,d,e 4.5 (2.1-12.5) 6.1 (2.0-35) 0.14
Peak troponin levelb,e 12.4 (4.7-44.3) 20.3 (4.1-73.6) 0.23
Creatinine levele 70 (59-86.5) 87 (74-100) <0.001
Numbers are counts (%) unless otherwise stated. Numbers of missing values varied from 45 (Systolic blood pressure) to 269 (troponine concentration II).
IQR interquartile range, CVD cardiovascular disease, PCI percutaneous coronary intervention, CABG coronary artery bypass graft surgery, AMI acute myocardial
infarction, IHD Ischemic heart disease, COPD chronic obstructive pulmonary disease, PAOD peripheral arterial occlusive Disease, LBBB left bundle branch block,
INR International normalized ratio. aCompeting acute conditions include infections, dementia, ileus etc. bStandardized against upper limit. cThe first troponin value
measured before CAG, dthe second troponin value measured before CAG. emedian (IQR)
Table 2 Relative contraindications as defined by national
guidelines
Female Male p-value
Uncontrolled hypertension 29 (13.1) 18 (8.0) 0.08
Fever or active infection 0 (0.0) 1 (1.47) 0.5
Malignant or terminal disease 11 (5.5) 4 (2.2) 0.12
Risk of bleeding 23 (14.7) 26 (17.3) 0.54
Ongoing bleeding 5 (2.0) 9 (3.6) 0.42
Moderate/severe heart failure 8 (3.2) 5 (2.0) 0.6
Previous allergy to contrast 0(0.0) 0(0.0) NA
Digoxin intoxication 0 (0.0) 0 (0.0) NA
Electrolyte-disturbances
(4.6 mM < potassium level < 3.5 mM)
49 (24.6) 29 (15.8) 0.031
At least one of the above
mentioned relative contraindication
(excluding heart failure)
130 (52.0) 120 (48.0) 0.060
Numbers are counts (%) unless otherwise stated
We used clinical data to quantify the distribution of relative contraindications
for men and women. The contraindications were not necessarily listed directly
by the physicians in the medical records
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Table 3 Univariable predictors of receipt of DCA at 60 days
OR 95 % CI p-value
Female 0.79 0.52-1.20 0.28
Age
< 60 years Reference
60-69 years 1.26 0.33-4.84 0.73
70-79 years 0.26 0.1-0.72 <0.001
≥ 80 years 0.04 0.02-0.10 <0.001
Admission to a hospital with invasive cardiac facilities 4.23 2.43-7.36 <0.001
Risk factors
Family history of CVD 6.99 3.31-14.79 <0.001
Arterial hypertension 1.67 1.09-2.55 0.019
Diabetes mellitus 0.72 0.42-1.26 0.25
Hypercholesteroleamia 4.21 2.36-7.52 <0.001
Smoking 1.91 1.45-2.52 <0.001
Prior PCI 3.07 0.71-13.33 0.14
Prior CABG 0.41 0.18-0.90 0.027
Previous AMI 1.5 0.43-5.28 0.53
Co-morbidities
Heart-related
Known IHD 1.12 0.59-2.10 0.73
Heart failure 0.67 0.36-1.25 0.21
Valvular heart disease 0.40 0.21-0.76 0.005
Atrial Fibrillation 0.36 0.21-0.60 <0.001
Other
COPD 0.33 0.18-0.60 <0.001
PAOD 0.81 0.37-1.79 0.60
Renal failure 0.11 0.04-0.30 <0.001
Neoplasia 0.88 0.28-2.80 0.84
Liver failure - - -
Stroke 0.19 0.10-0.33 <0.001
Symptoms
Chest pain 5.64 3.53-9.00 <0.001
Dyspnea 0.47 0.31-0.72 0.001
Neck pain 0.94 0.46-1.91 0.86
Diaphoresis 1.01 0.54-1.87 0.98
Nausea/vomiting 0.71 0.41-1.23 0.22
Fatigue 0.81 0.25-2.59 0.72
Abdominal pain 0.19 0.08-0.45 <0.001
Back pain 1.54 0.70-3.38 0.29
Cardiac arrest 0.76 0.33-1.78 0.53
ECG
ST-elevations 5.36 3.12-9.21 <0.001
ST-depressions 0.69 0.44-1.08 0.108
LBBB 0.52 0.26-1.03 0.06
Q-wave 0.62 0.36-1.06 0.08
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relative contraindications. Interestingly, non of the defined
relative contraindications were listed by the treating
physician as reasons for not performing DCA in any
patients. Of note, no patients with contrast allergy or
pregnancy were found in our cohort; as these contraindi-
cations may be considered more severe. Classical risk
factors such as family history of CVD, hypercholesterol-
emia, and smoking; symptoms of chest pain, and clinical
findings of ST-segment elevations were significant predic-
tors of an invasive strategy in our cohort. However,
women were more likely than men to present with atyp-
ical symptoms of nausea and vomiting. Similar findings
have been made in other studies [21, 22] and suggest that
increased vigilance is required when examining women in
the emergency setting. Use of computed coronary tomog-
raphy might be an option, as some trials suggest this
method is effective for identification of patients in need of
an invasive strategy [23].
By reviewing medical records containing the treat-
ing physicians’ reflections and rationale for opting out
an invasive treatment strategy in some patients, we
got a unique insight into the actual treating process
of patients with AMI. Noticeably, we found a trend
towards more cases of type 2 MI in women and a po-
tential confounding effect on the sex-DCA relation-
ship. This is in accordance with the findings of Saaby
et al. who showed a higher prevalence of type 2 MI
in women compared to men, and less cardiac cathe-
terizations in type 2 MI [24]. It is possible that type
2 MI plays a larger role in the sex-related differences
in treatment of AMI, than previously known.
Prior studies have proposed several hypotheses as to
why sex-related differences in the management of AMI
exist. It has been discussed if women were more likely
to refuse DCA than men. Golden et al. showed that
fewer women preferred DCA in the emergency room
and in-hospital [25]. Heidenreich et al. found that eld-
erly women were more likely to refuse DCA than men,
but the rate of refusals was low (5.1 %) [26]. In another
study, Mumma et al. found that female patients were
less likely to receive a cardiac catheterization recom-
mended by the physician, yet this could not explain the
gender gap [27]. In our study 17 % of those who were
not invasively investigated had refused DCA, without
any sex-related differences. Physicians’ reasons for not
adopting an invasive strategy in women compared to
men has previously been investigated [28], but no
study examining this issue based on medical records
in a real life setting is known by us. Although evi-
dence and guidelines supports that all patients with
AMI should undergo DCA, perhaps with the excep-
tion of low risk biomarker positive women [29], cases
where lack of evidence drives to omitting DCA in
patients with AMI exist. According to Poon et al.
Table 3 Univariable predictors of receipt of DCA at 60 days (Continued)
Other
Systolic BP 1.01 1.00-1.02 0.024
Diastolic BP 1.02 1.01-1.04 0.002
HR 0.99 0.98-1.00 0.010
Troponine 1 0.99 0.99-1.00 0.028
Troponine 2 1.00 1.00-1.00 0.34
Peak troponine 1.00 1.00-1.00 0.59
Creatinine 0.98 0.97-0.99 <0.001
CVD cardiovascular disease, PCI percutaneous coronary intervention, CABG coronary artery bypass graft surgery, AMI acute myocardial infarction, IHD Ischemic
heart disease, COPD Chronic obstructive pulmonary disease, PAOD Peripheral Arterial Occlusive Disease, LBBB left bundle branch block, ECG Electrocardiogram
Table 4 Multivariable predictors of receipt of DCA at 60 days
OR 95 % CI p-value
Age 0.90 0.87-0.94 <0.001
Admission to center 2.8 1.27-6.21 0.011
Family history of CVD 2.35 0.92-5.97 0.072
Arteriel hypertension 2.38 1.23-4.62 0.010
Hypercholesteroleamia 3.00 1.38-6.48 0.005
Smoking 2.03 1.39-2.97 <0.001
Prior CABG 0.25 0.06-0.98 0.047
Co-morbidities
Heart-related
Known IHD 3.85 1.27-11.63 0.017
Other
COPD 0.37 0.15-0.87 0.023
Renal failure 0.20 0.05-0.83 0.027
Stroke 0.31 0.13-0.70 0.005
Symptoms
Chest pain 2.99 1.58-5.67 0.001
ECG
ST-elevations 4.44 2.05-9.60 0.000
Q-wave 0.35 0.15-0.78 0.011
CABG coronary artery bypass graft surgery, COPD Chronic obstructive
pulmonary disease, CVD cardiovascular disease, ECG Electrocardiogram,
IHD Ischemic heart disease
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significantly more women than men were not referred
for DCA because the physician found that it was not
supported by evidence [28]. In our study the decision
not to refer to a coronary angiography was justified in
more than 80 % of the cases, but in the remainder of
patients an assessment of indications for cardiac
catheterization was not provided. Interestingly, women
were more prevalent in this subset of patients. This
finding emphasizes the importance of considering and
documenting clinical decisions; especially when devi-
ating from guideline-recommended treatments.
Strengths and limitations
Our study included detailed data from medical re-
cords representing the actual information available to
the treating physicians. This provided unique insights
to the clinical decision underlying referral to cardiac
catheterization in a real world-setting.
Our study has some important limitations. First, this
was an observational study prohibiting any conclusion
regarding causality. Second, given the retrospective
data collection process some degree of misclassifica-
tion cannot be ruled out. Hence, contradictory or
inconsistent descriptions in the medical records may
have resulted in misinterpretation or missing. We ad-
dressed this issue by checking reproducibility through
standardized extraction sheets, a specially trained data
collector and extensive rereading of the first 80 pa-
tients medical records. Third, we did not have infor-
mation on the level of training or specialization of
the treating physicians; particularly the physician who
decided whether or not the patient should receive an
invasive treatment strategy. Finally, the sample size
Fig. 2 Reasons for omitting DCA stated in the medical records by the treating physicians. The y-axis indicates number of patients. It was
possible for the patients to be categorized in more than one of the groups. 23 patients were categorized in two groups, 1 patient was
categorized in three groups. *This category includes risk of bleeding due to vitamin K antagonist treatment, pace maker implantation of
higher priority than DCA, etc
Bjerking et al. BMC Cardiovascular Disorders  (2016) 16:120 Page 9 of 11
was small and the study thus underpowered to detect
significant differences in the subset analyses of clinical
justifications. However, logistic and practical con-
straints made it impossible to include more than 500
patients.
Conclusion
In this contemporary matched cohort of patients hos-
pitalized with a first AMI we found that patient char-
acteristics differed between women and men despite
similar age. Although women had a lower risk for
DCA at 60 days than men, we were unable to detect
any differences in the distribution of relative contrain-
dications for coronary angiography between the sexes.
In patients not referred for DCA, physicians did not
document any reasons for opting out this procedure
in one fifth of patients. Thus, physicians should focus
on managing both women and men in accordance
with current guidelines and only refrain from using
DCA when evidence-driven. Finally, type 2 MI poses
a potential confounder for the sex-DCA relationship
and merits further investigations.
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